Smokers with chronic myeloid leukemia are at a higher risk of disease progression and premature death

Background: Smoking is suspected to not only be a risk factor for chronic myeloid leukemia but an adverse prognostic factor for the disease as well. The objective of the current study was to investigate the impact of smoking on survival and progression to advanced phases of disease. Methods: Based o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Lauseker, Michael (VerfasserIn) , Saußele, Susanne (VerfasserIn) , Hehlmann, Rüdiger (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: February 13, 2017
In: Cancer
Year: 2017, Jahrgang: 123, Heft: 13, Pages: 2467-2471
ISSN:1097-0142
DOI:10.1002/cncr.30636
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1002/cncr.30636
Verlag, Volltext: https://onlinelibrary-wiley-com.ezproxy.medma.uni-heidelberg.de/doi/abs/10.1002/cncr.30636
Volltext
Verfasserangaben:Michael Lauseker, PhD, Joerg Hasford, MD, Susanne Saussele, MD, Stephan Kremers, MD, Doris Kraemer, MD, Walter Lindemann, MD, Rüdiger Hehlmann, MD, and Markus Pfirrmann, PhD, for the German CML Study Group

MARC

LEADER 00000caa a2200000 c 4500
001 1575837382
003 DE-627
005 20230427042917.0
007 cr uuu---uuuuu
008 180530s2017 xx |||||o 00| ||eng c
024 7 |a 10.1002/cncr.30636  |2 doi 
035 |a (DE-627)1575837382 
035 |a (DE-576)505837382 
035 |a (DE-599)BSZ505837382 
035 |a (OCoLC)1341010161 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Lauseker, Michael  |d 1981-  |e VerfasserIn  |0 (DE-588)1058710265  |0 (DE-627)79743223X  |0 (DE-576)414848438  |4 aut 
245 1 0 |a Smokers with chronic myeloid leukemia are at a higher risk of disease progression and premature death  |c Michael Lauseker, PhD, Joerg Hasford, MD, Susanne Saussele, MD, Stephan Kremers, MD, Doris Kraemer, MD, Walter Lindemann, MD, Rüdiger Hehlmann, MD, and Markus Pfirrmann, PhD, for the German CML Study Group 
264 1 |c February 13, 2017 
300 |a 5 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 30.05.2018 
520 |a Background: Smoking is suspected to not only be a risk factor for chronic myeloid leukemia but an adverse prognostic factor for the disease as well. The objective of the current study was to investigate the impact of smoking on survival and progression to advanced phases of disease. Methods: Based on the data of the German CML Study IV, the authors analyzed the effect of smoking using a multivariate Cox model with the addition of the European Treatment and Outcome Study (EUTOS) long-term survival score variables of age, spleen size, thrombocytes, and peripheral blasts as well as sex, comorbidities, and type of treatment center. Results: The 8-year survival probability was 87% for a nonsmoking patient and 83% for a patient who smoked. The authors noted a 2.08-times higher risk of death for smokers in comparison with nonsmokers and a 2.11-times higher cause-specific hazard of disease progression. An interaction between smoking and age was found in the model for survival. No significant difference with regard to molecular response was observed. Conclusions: Even when considering differences in socioeconomic status and lifestyle between patients who smoke and nonsmokers, the current analysis demonstrated that smoking also might affect disease biology. The results of the current study indicate that patients with chronic myeloid leukemia, in particular those aged <60 years, should be encouraged to quit smoking. 
650 4 |a mortality 
650 4 |a prognosis 
650 4 |a chronic myeloid leukemia (CML) 
650 4 |a progression 
650 4 |a smoking 
700 1 |a Saußele, Susanne  |d 1968-  |e VerfasserIn  |0 (DE-588)115839860  |0 (DE-627)69162786X  |0 (DE-576)29010694X  |4 aut 
700 1 |a Hehlmann, Rüdiger  |d 1941-  |e VerfasserIn  |0 (DE-588)1037003489  |0 (DE-627)751737879  |0 (DE-576)390939463  |4 aut 
773 0 8 |i Enthalten in  |t Cancer  |d New York, NY : Wiley-Liss, 1948  |g 123(2017), 13, Seite 2467-2471  |h Online-Ressource  |w (DE-627)271350334  |w (DE-600)1479932-7  |w (DE-576)078590884  |x 1097-0142  |7 nnas  |a Smokers with chronic myeloid leukemia are at a higher risk of disease progression and premature death 
773 1 8 |g volume:123  |g year:2017  |g number:13  |g pages:2467-2471  |g extent:5  |a Smokers with chronic myeloid leukemia are at a higher risk of disease progression and premature death 
856 4 0 |u http://dx.doi.org/10.1002/cncr.30636  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://onlinelibrary-wiley-com.ezproxy.medma.uni-heidelberg.de/doi/abs/10.1002/cncr.30636  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20180530 
993 |a Article 
994 |a 2017 
998 |g 1037003489  |a Hehlmann, Rüdiger  |m 1037003489:Hehlmann, Rüdiger  |d 60000  |e 60000PH1037003489  |k 0/60000/  |p 7 
998 |g 115839860  |a Saußele, Susanne  |m 115839860:Saußele, Susanne  |d 60000  |d 61200  |e 60000PS115839860  |e 61200PS115839860  |k 0/60000/  |k 1/60000/61200/  |p 3 
999 |a KXP-PPN1575837382  |e 3010790856 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Michael Lauseker, PhD, Joerg Hasford, MD, Susanne Saussele, MD, Stephan Kremers, MD, Doris Kraemer, MD, Walter Lindemann, MD, Rüdiger Hehlmann, MD, and Markus Pfirrmann, PhD, for the German CML Study Group"]},"recId":"1575837382","id":{"doi":["10.1002/cncr.30636"],"eki":["1575837382"]},"title":[{"title":"Smokers with chronic myeloid leukemia are at a higher risk of disease progression and premature death","title_sort":"Smokers with chronic myeloid leukemia are at a higher risk of disease progression and premature death"}],"person":[{"role":"aut","family":"Lauseker","display":"Lauseker, Michael","roleDisplay":"VerfasserIn","given":"Michael"},{"family":"Saußele","given":"Susanne","roleDisplay":"VerfasserIn","display":"Saußele, Susanne","role":"aut"},{"roleDisplay":"VerfasserIn","display":"Hehlmann, Rüdiger","given":"Rüdiger","family":"Hehlmann","role":"aut"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"origin":[{"dateIssuedDisp":"February 13, 2017","dateIssuedKey":"2017"}],"language":["eng"],"note":["Gesehen am 30.05.2018"],"relHost":[{"pubHistory":["1.1948 -"],"recId":"271350334","id":{"doi":["10.1002/(ISSN)1097-0142"],"issn":["1097-0142"],"eki":["271350334"],"zdb":["1479932-7"]},"titleAlt":[{"title":"Cancer cytopathology"}],"title":[{"title_sort":"Cancer","subtitle":"interdisciplinary international journal of the American Cancer Society","title":"Cancer"}],"part":{"year":"2017","pages":"2467-2471","issue":"13","volume":"123","text":"123(2017), 13, Seite 2467-2471","extent":"5"},"type":{"bibl":"periodical","media":"Online-Ressource"},"origin":[{"dateIssuedKey":"1948","publisherPlace":"New York, NY","dateIssuedDisp":"1948-","publisher":"Wiley-Liss"}],"language":["eng"],"disp":"Smokers with chronic myeloid leukemia are at a higher risk of disease progression and premature deathCancer","physDesc":[{"extent":"Online-Ressource"}],"note":["Gesehen am 06.12.2011"]}],"physDesc":[{"extent":"5 S."}]} 
SRT |a LAUSEKERMISMOKERSWIT1320